Screener
Odyssey Therapeutics ODTX NLRP1 — Business Combination Contingent Consideration Liability Measurement Input
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Odyssey Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput.
The source filing: Odyssey Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335822
| Significant Unobservable Inputs | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Discount rate | 22.1% | 15.6% |
| Projected milestone timing | 3.00 to 11.26 Years | 2.25 to 11.75 Years |
| Probability of milestone achievement - NLRP1 program | 5.0% - 35.0% | 5.0% - 35.0% |
| Probability of milestone achievement - MDA5 program | 5.0% - 35.0% | 5.0% - 35.0% |
Item 1. Financial Statements.
FAQ
- What is Odyssey Therapeutics's NLRP1 — business combination contingent consideration liability measurement input?
- Odyssey Therapeutics (ODTX) reported NLRP1 — business combination contingent consideration liability measurement input of 3,500% in Q2 2026.
- What does NLRP1 — business combination contingent consideration liability measurement input mean?
- This metric represents the quantitative inputs and valuation assumptions used to determine the fair value of contingent consideration liabilities associated with the acquisition of NLRP1-related assets. It reflects the estimated probability-weighted cash flows, discount rates, and clinical milestone achievement timelines tied to the development of these specific therapeutic candidates. As a clinical-stage company, these inputs are critical for assessing the financial impact of future earn-out obligations on the balance sheet.
Ask your AI about Odyssey Therapeutics's nlrp1 — business combination contingent consideration liability measurement input.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude